Search for: "Classen Immunotherapies, Inc." Results 21 - 40 of 62
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Dec 2008, 8:00 pm
In a nonprecedential opinion today, Classen Immunotherapies, Inc. v. [read post]
12 Aug 2012, 11:47 am by Charles Bieneman
Ct. 1289 (2012), according to the District Court in Classen Immunotherapies, Inc. v. [read post]
9 Aug 2009, 12:44 am
Integra and patents on research tools -->In Classen Immunotherapies v. [read post]
1 Sep 2011, 8:31 am by Stefanie Levine
On August 31, 2011, the Federal Circuit issued its second decision in Classen Immunotherapies, Inc. v. [read post]
1 Dec 2010, 9:59 pm by Patent Docs
Mayo Collaborative Services and Classen Immunotherapies, Inc. v. [read post]
26 Jun 2013, 1:11 pm by Eric Guttag
The Way Forward from Mayo Collaborative Services is through the Classen Immunotherapies Remand*The reasoning in Mayo Collaborative Services makes no patent law logical sense on numerous grounds, including disregarding an important paragraph in the Supreme Court’s 1981 case of Diamond v. [read post]
1 Sep 2011, 8:31 am by Stefanie Levine
On August 31, 2011, the Federal Circuit issued its second decision in Classen Immunotherapies, Inc. v. [read post]
31 Aug 2011, 1:05 pm
Classen Immunotherapies  v. [read post]
5 Jul 2010, 11:19 am by Jim Singer
Mayo Collaborative Services and Classen Immunotherapies, Inc. [read post]
17 Mar 2013, 9:07 am by Gene Quinn
Related posts:The Way Forward from Mayo Collaborative Services is through the Classen Immunotherapies Remand*The reasoning in Mayo Collaborative Services makes no patent law logical sense on numerous grounds, including disregarding an important paragraph in the Supreme Court’s 1981 case of Diamond v. [read post]
13 Dec 2010, 2:00 am by Stefanie Levine
Mayo Collaborative Services, No. 2008-1403, and Classen Immunotherapies, Inc. v. [read post]
13 Dec 2010, 2:00 am by Stefanie Levine
Mayo Collaborative Services, No. 2008-1403, and Classen Immunotherapies, Inc. v. [read post]
3 Nov 2011, 12:48 pm by Dennis Crouch
Kappos; (2) inconsistencies in application of the law apparent from the court's recent decisions in Ultramercial, Classen Immunotherapies v. [read post]
7 Sep 2011, 4:22 am by Marie Louise
  Highlights this week included: US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al (Inventive Step) (Orange Book Blog) (Patently-O) (Patent Docs) (Patent Docs) (IPBiz) (Patent Law Practice Center) (Patent Baristas) US: FTC issues long-awaited final report on authorized generics; report examines both the short-term effects and long-term impact on competition and drug prices (FDA Law Blog) (Orange Book Blog)  … [read post]
30 Jan 2012, 3:49 am by SteinMcewen, LLP
Repeating principles previously set forth in Classen Immunotherapies and Research Corp., the panel emphasized the Patent Act’s wide boundaries. [read post]
17 Dec 2010, 11:18 am by Matt Osenga
The other interesting case in this area in which the Supreme Court issued a GVR Order is Classen Immunotherapies, Inc. v. [read post]
9 May 2012, 4:25 am by Gene Quinn
The Way Forward from Mayo Collaborative Services is through the Classen Immunotherapies Remand*The reasoning in Mayo Collaborative Services makes no patent law logical sense on numerous grounds, including disregarding an important paragraph in the Supreme Court’s 1981 case of Diamond v. [read post]
15 Sep 2010, 8:39 am by Dennis Crouch
Related cases include Classen Immunotherapies Inc. v. [read post]